Author: Kathy Whitney
Feb. 11, 2015—Nine steps to a healthier heart.
Feb. 5, 2015—Vanderbilt is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart.
Jan. 21, 2015—Vanderbilt University Medical Center researchers have found that bathing critically ill patients with disposable chlorhexidine cloths did not decrease the incidence of health care-associated infections when compared to less expensive nonantimicrobial cloths, according to a study appearing online in JAMA this week.
Jan. 15, 2015—The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).
Dec. 18, 2014—High consumption of trans fatty acids (TFA) has been linked to increased risk of heart disease, stroke and even cancer.
Nov. 18, 2014—A copy repairman who couldn’t do his job anymore and was forced to take medical leave has returned to work. A woman who couldn’t walk from her car to her desk job has enough energy to redecorate her house. A 42-year-old mother who was too sick to care for her children and was discharged to...
Nov. 13, 2014—Two Vanderbilt University School of Medicine students are among 11 individuals nationwide to receive Sarnoff Foundation Medical Student Research Fellowship awards for 2014-2015.
Oct. 30, 2014—Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy.
Oct. 16, 2014—Carrie Romero of Columbia, Tennessee, is running for her life. In 1997, when she was 28, Romero was diagnosed with dilated cardiomyopathy — a heart muscle disease that puts her at risk for sudden cardiac arrest (SCA).
Oct. 9, 2014—Vanderbilt Heart and Vascular Institute (VHVI) reached a significant milestone recently with the 100th implantation of the miniaturized HeartWare HVAD Pump, a left ventricular assist device (LVAD) that supports the heart.
Oct. 2, 2014—The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States.
Oct. 2, 2014—Vanderbilt Heart and Vascular Institute (VHVI) recently hosted a cardiovascular health screening for participants in a nonprofit organization called the Enplay Foundation, for middle and high school athletes and their adult family members.